(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three biggest winners today are SmileDirectClub, Advanced Semiconductor Engineering, and VerifyMe.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 SmileDirectClub (SDC) 0.68 4.34% 2022-11-18 07:33:21
2 Advanced Semiconductor Engineering (ASX) 6.50 3.17% 2022-11-18 04:24:42
3 VerifyMe (VRME) 1.36 3.03% 2022-11-18 04:08:39
4 Groupon (GRPN) 8.85 3.03% 2022-11-18 04:11:53
5 Sorrento Therapeutics (SRNE) 1.47 2.8% 2022-11-18 07:29:53
6 Everbridge (EVBG) 30.90 2.28% 2022-11-18 04:08:13
7 Matterport
(MTTR)
3.45 2.07% 2022-11-18 07:26:14
8 Matterport
(MTTR)
3.45 2.07% 2022-11-18 07:26:14
9 FuboTV (FUBO) 3.11 1.97% 2022-11-18 07:20:40
10 Banco Santander (SAN) 2.69 1.89% 2022-11-18 07:17:38

The three biggest losers today are Xenetic Biosciences, Kinross Gold, and Tattooed Chef.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Xenetic Biosciences (XBIO) 0.37 -15.05% 2022-11-18 07:32:46
2 Kinross Gold (KGC) 3.95 -3.19% 2022-11-18 04:29:41
3 Tattooed Chef (TTCF) 2.34 -2.5% 2022-11-18 07:21:18
4 Sypris Solutions (SYPR) 2.12 -2.3% 2022-11-18 04:07:24
5 Niu Technologies (NIU) 3.65 -1.88% 2022-11-18 07:17:23
6 Leggett & Platt (LEG) 33.99 -1.34% 2022-11-18 04:14:54
7 Inovio Pharmaceuticals (INO) 2.31 -1.28% 2022-11-18 07:27:33
8 Viking Therapeutics (VKTX) 4.06 -0.98% 2022-11-18 04:18:42
9 Ryanair Holdings (RYAAY) 73.81 -0.83% 2022-11-18 04:22:25
10 Banco Santander Brasil (BSBR) 5.10 -0.78% 2022-11-18 04:10:32

Premarket Winners today

1. SmileDirectClub (SDC) – Premarket: 4.34%

SmileDirectClub, Inc., a dental care company, provides clear aligner therapy. It manages all aspects of the treatment process including marketing, manufacturing and fulfillment. The company also monitors patients through their progress through treatment. SmileCheck, Inc. has approximately 250 dentists in America, Canada, Australia and New Zealand. The company also sells aligners and impression and whitening kit, whitening gels and retainers. It also stocks toothbrushes and toothpastes as well as water flossers and SmileSpa and other ancillary products. It was established in Nashville, Tennessee in 2014.

NASDAQ ended the session with SmileDirectClub falling 5.67% to $0.65 on Friday, after three sequential sessions in a row of losses. NASDAQ dropped 0.35% to $11,144.96, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.334.

Sales Growth

SmileDirectClub’s sales growth is negative 28.2% for the current quarter and negative 22.1% for the next.

Revenue growth

Annual revenue growth fell by 27.8%. The twelve-month trailing month’s total is 541.41M.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

SmileDirectClub’s stock is considered to be overbought (>=80).

More news about SmileDirectClub.

2. Advanced Semiconductor Engineering (ASX) – Premarket: 3.17%

ASE Technology Holding Co. Ltd. offers a variety of electronic manufacturing services, including testing and packaging of semiconductors. The company offers package services including chip scale packaging (CSP) and flip-chip ball grid arrays (BGA), as well as advanced and low profile quad flat packages. It also provides bump chip carrier, QFN (Quick Flat No Lead) packages and plastic BGAs. 3D chip packages are available, along with stackable die solutions in different packages. There is also copper and silver wire bonding. Advanced packages include flip chip BGA, heat-spreader FCCBGA, flip-chip CSP and hybrid FCCSP. Flip chip package in package and on package (POP), advanced single-sided substrate; high bandwidth POP; fan out wafer-level packaging; and SESUB. It also offers IC wire bonding packaging, system-in-package (SiP), and module packages, and interconnect materials. Further, the company provides a range of semiconductor testing services, including front-end engineering testing, wafer probing, logic/mixed-signal/RF module and SiP/MEMS/discrete final testing, and other test-related services, as well as drop shipment services. It also develops, builds, leases and manages real property properties. Kaohsiung is the headquarters of this company, which was founded in 1984.

NYSE ended the session with Advanced Semiconductor Engineering rising 1.86% to $6.30 on Friday while NYSE dropped 0.27% to $15,223.96.

Earnings per Share

Advanced Semiconductor Engineering’s trailing twelve-month EPS is $0.53.

PE Ratio

Advanced Semiconductor Engineering’s trailing 12 months earnings to price ratio is 11.92. The purchaser of the shares is therefore investing $11.92 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the business’ profitability relative to shareholders’ equity, was 28.76%.

More news about Advanced Semiconductor Engineering.

3. VerifyMe (VRME) – Premarket: 3.03%

Together with PeriShip Global, LLC, VerifyMe, Inc. operates as a technology solution provider. They specialize in connecting brands and consumers, providing logistics support for brands, and ensuring that their products are delivered on time. Two segments of the company are VerifyMe Solutions or PeriShip Global Solutions. VerifyMe Solutions is a technology segment that connects brands and consumers. This allows brand owners to collect business intelligence, while engaging with their customers directly. The solutions it offers provide brand protection, supply chain functions such as authentication, serialization and counterfeit prevention. They also offer track and trace capabilities for packaging labels and products. The segment offers customer engagement, customized printing of tamper-evident labels using visible and invisible variable codes and images printed using its proprietary inks. PeriShip Global Solutions offers predictive analytics to optimize delivery time and temperature sensitive perishable goods. PeriTrack’s segment offers customers an integrated portal that gives them a detailed view of their shipping activities using real-time data. The company also offers pre-transit and post-delivery call centers, as well as weather/traffic service. INX International Ink Company is the strategic partner of VerifyMe. The company used to be known as LaserLock Technologies, Inc., but changed its name in July 2015 to VerifyMe, Inc. VerifyMe, Inc. is an American company that was founded in 1999. Its headquarters are in Rochester, New York.

NASDAQ ended the session with VerifyMe falling 0.75% to $1.32 on Friday, following the last session’s downward trend. NASDAQ dropped 0.35% to $11,144.96, after two sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, VerifyMe has a trailing twelve months EPS of $-1.483.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -54.47%.

Volatility

VerifyMe last week’s and last month’s intraday variations averages were negative 0.12% and 0.28% respectively.

VerifyMe had the highest average volatility amplitude at 2.37% last week, 3.75% last month and 4.27% in the quarter.

Yearly Top and Bottom Value

VerifyMe’s stock is valued at $1.32 at 07:34 EST, way under its 52-week high of $4.27 and way above its 52-week low of $1.01.

Revenue growth

The year-on-year revenue growth was 3526.6%. We now have 5.21M in the 12 trailing months.

Classification of Stock Prices

The stochastic oscillator is a helpful indicator for overbought or oversold situations.

VerifyMe stock is overbought (>=80).

More news about VerifyMe.

4. Groupon (GRPN) – Premarket: 3.03%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon jumping 0.47% to $8.59 on Friday, following the last session’s upward trend. NASDAQ dropped 0.35% to $11,144.96, after two successive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Earnings per Share

Groupon’s trailing 12 months profit per share is $-10.07.

For the 12 trailing months, the company’s return-on-equity, which is a measure of profitability relative to shareholders’ equity, was negative at -17.51%.

More news about Groupon.

5. Sorrento Therapeutics (SRNE) – Premarket: 2.8%

Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California.

NASDAQ ended the session with Sorrento Therapeutics sliding 6.03% to $1.43 on Friday, after four consecutive sessions in a row of losses. NASDAQ slid 0.35% to $11,144.96, after two sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -206.57%.

Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $1.43 at 07:34 EST, way below its 52-week high of $6.74 and way above its 52-week low of $1.15.

Moving Average

Sorrento Therapeutics’s stock value is far below its 50-day moving mean of $1.71, and much lower than its 200-day moving median of $2.13.

Revenue growth

The year-on-year revenue growth was 29%. We now have 57.03M in the 12 trailing months.

Sales Growth

Sorrento Therapeutics’s sales growth is 29% for the present quarter and 85.1% for the next.

More news about Sorrento Therapeutics.

6. Everbridge (EVBG) – Premarket: 2.28%

Everbridge, Inc. is a software company that provides software solutions to automate and speed up organizations’ response to major events, both domestically and internationally. Critical Event Management is a platform that offers software-as-a-service. It includes various software programs to help organizations manage critical events. The company serves small and medium-sized businesses as well as educational and government agencies. It is available to all levels of technology, finance, health, life sciences, manufacturing and media, education and retail. 3n Global, Inc. was the company’s previous name. In April 2009, Everbridge, Inc. became Everbridge, Inc. It was established in 2002. The headquarters are located in Burlington in Massachusetts.

NASDAQ ended the session with Everbridge sliding 6.41% to $30.21 on Friday while NASDAQ fell 0.35% to $11,144.96.

Earnings per Share

Everbridge’s trailing 12 months profit per share is $-2.7

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was negative at -28.25%.

Volatility

Everbridge’s intraday variation average for the week and quarter ended last week at a negative 2.08% and a negative 0.14 respectively.

Everbridge had the highest average volatility amplitude at 2.88%, 4.91% and 3.92% respectively.

More news about Everbridge.

7. Matterport
(MTTR) – Premarket: 2.07%

Matterport, Inc., is a company that specializes in spatial data. It focuses on the digitization and datafication, of the built environment. Matterport digital twins is a 3D platform that allows you to create, manage, encourage, and analyze spaces. Matterport Capture is an app that captures depth and data of spaces using 3D cameras and 360 cameras. Matterport Workshop allows users to modify, share and customize the space. Matterport Showcase lets people view space and allow them to explore it in their final form. Matterport VR allows you to live in virtual reality. The company offers services in real estate, hospitality, tourism, insurance, restoration, manufacturing, engineering, construction, as well as retail. Matterport, Inc., was established in 2011, and has its headquarters in Sunnyvale, California.

NASDAQ ended the session with Matterport
falling 4.25% to $3.38 on Friday, after four sequential sessions in a row of losses. NASDAQ fell 0.35% to $11,144.96, after two sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Earnings per Share

Matterport’s trailing 12 months profit per share is $-3.367.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was negative at -75.04%.

Annual Top and Bottom Value

Matterport’s stock was valued at $3.38 as of 07:35 EST at 7:35 EST. This is way below its 52-week peak of $37.60, and far above its 52 week low of $2.85.

Revenue growth

The year-on-year revenue growth was 5.9%. 112.75M is now available for the 12 trailing months.

More news about Matterport
.

8. Matterport
(MTTR) – Premarket: 2.07%

Matterport, Inc., a spatial data company, focuses on digitization and datafication of the built world. It offers Matterport digital twins, a 3D data platform to design, build, operate, promote, and understand spaces. The company offers Matterport Capture, an application that enables to capture depth, data, and imagery of a space using 3D cameras, 360 cameras, and iPhones; Matterport Workshop application to customize, add additional details, and share spaces; Matterport Showcase application for audience view and explore space in its final format; and Matterport VR to experience virtual reality. It offers solutions for real estate, photography, travel and hospitality, retail, insurance and restoration, industrial and facilities management, architecture, and engineering and construction industries. Matterport, Inc. was founded in 2011 and is headquartered in Sunnyvale, California.

NASDAQ ended the session with Matterport
dropping 4.25% to $3.38 on Friday while NASDAQ slid 0.35% to $11,144.96.

Earnings per Share

Matterport’s trailing 12 months profit per share is $-3.367.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a company, was negative at -75.04%.

More news about Matterport
.

9. FuboTV (FUBO) – Premarket: 1.97%

fuboTV Inc. operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. Its fuboTV platform allows customers to access content through streaming devices, as well as on SmartTVs, computers, mobile phones, and tablets. The company is headquartered in New York, New York.

NYSE ended the session with FuboTV sliding 5.14% to $3.05 on Friday, after four sequential sessions in a row of losses. NYSE dropped 0.27% to $15,223.96, after two successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, FuboTV has a trailing twelve months EPS of $-3.735.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -66.53%.

Volume

Today’s last reported volume for FuboTV is 9864250 which is 19.52% below its average volume of 12257200.

More news about FuboTV.

10. Banco Santander (SAN) – Premarket: 1.89%

Banco Santander S.A. offers a variety of retail and commercial banking services and products to small and medium-sized businesses, as well as large corporations worldwide. You can get demand and time deposits as well as current and savings accounts. Mortgages, consumer finance and syndicated corporate loans are also available. Cash management, corporate finance, corporate finance, corporate finance and insurance products are all offered. Private banking services are also offered by the company, which provides wealth, cash and asset management. It is also involved in corporate banking, treasury and risk hedging; foreign trade, confirmation, custody, investment banking, as well as other activities. It has 9,879 branches. The original name of the company was Banco Santander Central Hispano S.A., but it changed its name in June 2007 to Banco Santander S.A. Banco Santander, S.A., was established in Madrid, Spain in 1856.

NYSE ended the session with Banco Santander sliding 0.8% to $2.64 on Friday while NYSE slid 0.27% to $15,223.96.

Earnings Per Share

As for profitability, Banco Santander has a trailing twelve months EPS of $-0.668.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.13%.

Volatility

The current intraday variation of Banco Santander was positive 0.19, negative 0.07, and positive 2.29 for the week and quarter.

Banco Santander had the highest average volatility amplitude at 0.94%, 2.04% and 2.29% respectively.

More news about Banco Santander.

Premarket Losers Today

1. Xenetic Biosciences (XBIO) – Premarket: -15.05%

Xenetic Biosciences, Inc. is a biopharmaceutical firm that focuses on XCART, a customized chimeric receptor T cell (CART) platform technology designed to target specific patient-specific tumour neoantigens. It is involved in research and development of oncology therapies and biologic drugs. Cell-based therapies that target the B-cell receptor are developed to treat B-cell lymphomas. By partnering with pharmaceutical and biotech companies, it is also using PolyXen, their proprietary drug delivery platform. Takeda Pharmaceutical Co. Ltd. and Serum Institute of India Limited have signed collaboration agreements. Xenetic Biosciences, Inc. has its headquarters in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences dropping 0% to $0.44 on Friday, after two sequential sessions in a row of losses. NASDAQ slid 0.35% to $11,144.96, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.29%.

Volume

Today’s last reported volume for Xenetic Biosciences is 51037 which is 10.64% above its average volume of 46126.

Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $0.44 at 07:36 EST, under its 52-week low of $0.45.

Classification of Stock Prices

The stochastic oscillator is a helpful indicator for overbought or oversold situations.

Xenetic Biosciences is oversold (=20).

More news about Xenetic Biosciences.

2. Kinross Gold (KGC) – Premarket: -3.19%

Kinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, the Russian Federation, Brazil, Chile, Ghana, and Mauritania. It is also involved in the extraction and processing of gold-containing ores; reclamation of gold mining properties; and production and sale of silver. Kinross Gold Corporation was founded in 1993 and is headquartered in Toronto, Canada.

NYSE ended the session with Kinross Gold sliding 1.33% to $4.08 on Friday while NYSE fell 0.27% to $15,223.96.

Earnings Per Share

As for profitability, Kinross Gold has a trailing twelve months EPS of $1.06.

PE Ratio

Kinross Gold has a trailing twelve months price to earnings ratio of 3.84. Meaning,
the purchaser of the share is investing $3.84 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.75%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Kinross Gold’s stock is considered to be overbought (>=80).

Revenue growth

The year-on-year revenue growth was 16%. We now have 3.85B in the 12 trailing months.

More news about Kinross Gold.

3. Tattooed Chef (TTCF) – Premarket: -2.5%

Tattooed Chef, Inc., is a company that produces and sells frozen food products. The company supplies American retailers with plant-based products. It offers ready-to cook bowls and zucchini spirals as well as acai, smoothie, and cauliflower pizza. The company’s frozen foods are sold under the Tattooed Chef and private label brands. It had approximately 14,000 outlets as of December 31, 2021. Tattooed Chef, Inc. has its headquarters in Paramount, California.

NASDAQ ended the session with Tattooed Chef falling 12.59% to $2.40 on Friday, after five consecutive sessions in a row of losses. NASDAQ dropped 0.35% to $11,144.96, after two successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Tattooed Chef has a trailing twelve months EPS of $-0.069.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.9%.

Volume

The current reported Tattooed Chef volume is 5609930, which is 563.07% higher than its 846045 average volume.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Tattooed Chef’s stock is considered to be overbought (>=80).

More news about Tattooed Chef.

4. Sypris Solutions (SYPR) – Premarket: -2.3%

Sypris Solutions, Inc. supplies truck parts, components for oil and gas pipelines, as well as aerospace and defense electronics, mainly in North America, Mexico, and Canada. Sypris Electronics and Sypris Technologies are its two main segments. Sypris Technologies supplies heat-treated, forged, machined and welded steel parts for commercial vehicles, off-highway vehicles, recreational vehicles, automobile, industrial, light trucks, and energy markets. The segment offers components such as axle shafts and transmission shafts, drive sets, gear sets and steer axle knuckles. It also offers value-added services for drivetrain assemblies and produces pressure closures, and other fabricated products to support oil and gas pipelines. Sypris Electronics offers electronic manufacturing services such as full-box and circuit build manufacturing, high reliability manufacture, system assembly and integration design for manufacturability and specification work in the aerospace and defense electronics markets. The segment offers circuit card assembly for electronic sensors, systems and weapons, as well as targeting and warning system services. It also offers value-added options such low-volume prototype assembly or high-volume turnkey production. It also provides engineering design, repair and inspection services. It also sells engineered products under its Tube Turns name. It was founded in 1997, and its headquarters are located in Louisville Kentucky.

NASDAQ ended the session with Sypris Solutions rising 1.4% to $2.17 on Friday, following the last session’s upward trend. NASDAQ slid 0.35% to $11,144.96, after two consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings per Share

Sypris Solutions’ trailing 12 month EPS is $0.079.

PE Ratio

Sypris Solutions’ trailing 12-month price-to-earnings ratio is 27.47. The purchaser of the shares is therefore investing $27.47 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the business’ profitability relative to shareholders’ equity, was 29.24%.

Revenue growth

The year-on-year revenue growth was 30.9%. We now have 103.62M in the 12 trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sypris Solutions’s stock is considered to be oversold (<=20).

Annual Top and Bottom Value

Sypris Solutions stock was valued at $2.17 as of 07:36 EST. This is way lower than the 52-week high at $4.07, and much higher than the 52-week low at $1.71.

More news about Sypris Solutions.

5. Niu Technologies (NIU) – Premarket: -1.88%

Niu Technologies manufactures and sells electric scooters. NQi (MQi), UQi (and Gova) series of electric scooters, motorcycles, as well as KQi (and BQi) series ebikes, NIU Aero, NIU Aero, and NQi Series e-bikes, RQi and Qi high-performance motorcycles, and YQi hybrid motorcycles. The company also offers accessories and spare parts, including raincoats. The company also offers its NIU App, an online repair request and DIY repairs as well as service station locator and theft reporting. Niu Technologies distributes its products and sells them through franchised shops, retailers, distributors and third-party online e-commerce platforms. It had 338 partners in cities and 3,108 franchised shops in around 239 Chinese cities. There were also 42 international distributors. Niu Technologies was founded in 2014. It is located in Beijing in the People’s Republic of China.

NASDAQ ended the session with Niu Technologies jumping 1.78% to $3.72 on Friday, following the last session’s upward trend. NASDAQ slid 0.35% to $11,144.96, after two sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings per Share

Niu Technologies’ trailing twelve-month EPS is $0.333.

PE Ratio

Niu Technologies’ trailing 12-month price-to-earnings ratio is 11.22. The purchaser of the shares is therefore investing $11.22 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the business’ profitability relative to shareholders’ equity, was 10.34%.

More news about Niu Technologies.

6. Leggett & Platt (LEG) – Premarket: -1.34%

Leggett & Platt, Incorporated manufactures, markets, and designs engineered products and components worldwide. The company operates in three main segments, including bedding products, specialized products, and furniture, flooring, and textile products. Steel rods and drawn wires are available, along with foam chemicals, additives, innersprings and specialty foams. The company also offers mechanical and pneumatic seat support, massage systems and motors for automobile seating, as well as seats suspension systems, actuators and motors. It also produces formed tubes and tube assemblies for fluid conveyance system, flexible joint components, titanium, nickel and stainless-steel tubing and engineered hydraulics for OEMs of automotive OEMs and Tier 1 suppliers. The company also offers motion hardware and steel mechanisms for sofas, lift chairs and sleeper couches; springs for soft seating, components, and private label products for soft seating. It also offers hard-surface flooring underlayment and carpet cushion, along with structural fabrics and geo components, to manufacturers of office and upholstered furniture. It was established in Carthage in Missouri in 1883.

NYSE ended the session with Leggett & Platt dropping 0.52% to $34.45 on Friday while NYSE fell 0.27% to $15,223.96.

Earnings per Share

Leggett & Platt’s trailing twelve-month EPS is $1.82.

PE Ratio

Leggett & Platt’s trailing 12-month price-to-earnings ratio is 18.93. The purchaser of the shares is therefore investing $18.93 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability of a company relative to shareholders’ equity, was 24.66%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 5.1%, now sitting on 5.31B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is a negative 31% and a negative 32.5%, respectively.

Volatility

Leggett & Platt’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.66%, a positive 0.02%, and a positive 1.96%.

Leggett & Platt’s highest amplitude of average volatility was 3.43% (last week), 2.18% (last month), and 1.96% (last quarter).

More news about Leggett & Platt.

7. Inovio Pharmaceuticals (INO) – Premarket: -1.28%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals sliding 0.02% to $2.34 on Friday while NASDAQ fell 0.35% to $11,144.96.

Earnings per Share

Inovio Pharmaceuticals’ trailing 12 months profit per share was $-1.073.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability of a company relative to shareholders’ equity, was negative at -87.99%.

Moving Average

Inovio Pharmaceuticals’s value is much higher than its 50 day moving average $1.92 or its 200-day moving median $2.46.

Volatility

Inovio Pharmaceuticals’s intraday variation average for the week and quarter ended last week was negative 0.9%. Last month’s and quarter’s were positive by 1.30% and positive by 4.41%.

Inovio Pharmaceuticals had the highest average volatility amplitudes of 4.37%, 3.85% and 4.41 percent (both last week)

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 3.4% and positive 46% for the next.

More news about Inovio Pharmaceuticals.

8. Viking Therapeutics (VKTX) – Premarket: -0.98%

Viking Therapeutics, Inc. is a biopharmaceutical company at the clinical stage. It focuses its efforts on developing novel treatments for metabolic and endocrinological disorders. VK2809 is the company’s leading drug candidate. It is an oral tissue-subtype select agonist and receptor-subtype selective antagonist of the thyroid hormone receptor alpha (TRss). The Phase IIb clinical trial is underway to treat non-alcoholic steatohepatitis patients. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRss for X-linked adrenoleukodystrophy. It was founded in 2012 in San Diego, California.

NASDAQ ended the session with Viking Therapeutics dropping 1.44% to $4.10 on Friday while NASDAQ dropped 0.35% to $11,144.96.

Earnings per Share

Viking Therapeutics’ trailing 12 months profit per share was $-0.599.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a company, was negative at -30.31%.

More news about Viking Therapeutics.

9. Ryanair Holdings (RYAAY) – Premarket: -0.83%

Ryanair Holdings plc and its subsidiaries provide scheduled passenger airline services throughout Europe, including the United Kingdom of Ireland, Spain, Italy, Spain, Germany, Germany, Spain, Italy, Spain and Germany. The company also provides ancillary services such as in-flight sales of drinks, food, duty free, merchandise, and car rental and accommodation services. It even offers travel insurance via its mobile app and website. The company also offers passenger and aircraft handling, ticketing and maintenance and repairs services. It markets car parking and fast-track airport transfers as well as attractions and activities through its mobile app and website. It had a fleet of 483 Boeing 737 planes and 29 Airbus A320 airplanes as its principal aircraft. The company also offered around 3,000 short-haul flights daily to approximately 225 airports. Ryanair Holdings plc, which was established in 1985 is headquartered at Swords in Ireland.

NASDAQ ended the session with Ryanair Holdings dropping 0.71% to $74.43 on Friday, after four consecutive sessions in a row of losses. NASDAQ dropped 0.35% to $11,144.96, after two successive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, Ryanair Holdings has a trailing twelve months EPS of $-7.24.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.11%.

More news about Ryanair Holdings.

10. Banco Santander Brasil (BSBR) – Premarket: -0.78%

Banco Santander (Brasil), S.A. and its subsidiaries offer a variety of banking products and services for individuals, small- and medium businesses, as well as corporate clients in Brazil. It operates two business segments: Global Wholesale Banking and Commercial Banking. The company offers bank deposits, digital prepaid solutions and payment platforms, loyalty programs, employee benefit vouchers, payroll loans and digital debt renegotiation and services, mortgages, home equity financing products, consumer credit, local loans and commercial and trade finance. The company also offers financial advisory and funding services in relation to the origination and distribution fixed-income securities in debt capital markets. It can finance acquisitions and syndicated loan financing, as well as subordinated debt, energy efficiency transactions, mortgages; home equity financing products; consumer credit; stock brokerage, advisory, equity and equity research services. The company also offers investment products, including derivatives and foreign currency, to institutional investors as well as corporate and retail clients. It provides market-making services. It also offers instant payment services, a range of services that are focused on the agricultural sector, microfinance, and online auto listing. It also provides financial products and services to customers via a multichannel distribution network that includes branches, mini-branches and ATMs as well as call centers, Internet banking and mobile banking. Banco Santander (Brasil), S.A., was established in 1985. It is located in Sao Paulo in Brazil.

NYSE ended the session with Banco Santander Brasil rising 0.1% to $5.14 on Friday, after four sequential sessions in a row of losses. NYSE dropped 0.27% to $15,223.96, after two sequential sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Earnings per Share

For profitability, Banco Santander Brasil’s trailing twelve-month EPS is $0.67

PE Ratio

Banco Santander Brasil’s trailing 12-month price-to-earnings ratio is 7.68. The purchaser of the shares is therefore investing $7.68 per dollar in annual earnings.

For the 12 trailing months, the company’s return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 17.64%.

Sales Growth

The quarter-end sales growth at Banco Santander Brasil is 6.9%.

More news about Banco Santander Brasil.

Stay up to date with our premarket winners and losers daily report